The Combined Blockade of β-Adrenoceptor and COX-2 During the Perioperative Period to Improve Long-term Cancer Outcomes

Int Anesthesiol Clin. Fall 2016;54(4):72-91. doi: 10.1097/AIA.0000000000000116.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenergic beta-Antagonists / pharmacology*
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
  • Catecholamines / metabolism
  • Cyclooxygenase 2 Inhibitors / adverse effects
  • Cyclooxygenase 2 Inhibitors / pharmacology*
  • Disease Progression
  • Humans
  • Inflammation / drug therapy
  • Neoplasms / metabolism
  • Neoplasms / surgery*
  • Perioperative Care
  • Perioperative Period
  • Postoperative Complications* / drug therapy
  • Postoperative Complications* / etiology
  • Prostaglandin Antagonists / adverse effects
  • Prostaglandin Antagonists / pharmacology*
  • Prostaglandins / metabolism
  • Receptors, Adrenergic
  • Stress, Physiological* / drug effects
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Anti-Inflammatory Agents, Non-Steroidal
  • Catecholamines
  • Cyclooxygenase 2 Inhibitors
  • Prostaglandin Antagonists
  • Prostaglandins
  • Receptors, Adrenergic